GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-06-16: Form 6-K; Period of report 2014-06-16; Description TRANSACTION IN OWN SHARES; Document gsk201406166k.htm.
- 2014-06-13: Form 6-K; Period of report 2014-06-13; Description TRANSACTION IN OWN SHARES; Document gsk201406136k1.htm.
- 2014-06-13: Form 6-K; Period of report 2014-06-13; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201406136k.htm.
- 2014-06-12: Form 6-K; Period of report 2014-06-12; Description TRANSACTION IN OWN SHARES; Document gsk201406126k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2014-06-16 | 6-K | 2014-06-16 | TRANSACTION IN OWN SHARES | gsk201406166k.htm |
| 2014-06-13 | 6-K | 2014-06-13 | TRANSACTION IN OWN SHARES | gsk201406136k1.htm |
| 2014-06-13 | 6-K | 2014-06-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201406136k.htm |
| 2014-06-12 | 6-K | 2014-06-12 | TRANSACTION IN OWN SHARES | gsk201406126k.htm |
| 2014-06-11 | 6-K | 2014-06-11 | TRANSACTION IN OWN SHARES | gsk201406116k3.htm |
| 2014-06-11 | 6-K | 2014-06-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201406116k2.htm |
| 2014-06-11 | 6-K | 2014-06-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201406116k1.htm |
| 2014-06-11 | 6-K | 2014-06-11 | INCRUSE ELLIPTA POSITIVE DATA STUDIES | gsk201406116k.htm |
| 2014-06-09 | 6-K | 2014-06-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201406096k1.htm |
| 2014-06-09 | 6-K | 2014-06-09 | TRANSACTION IN OWN SHARES | gsk201406096k.htm |
| 2014-06-06 | 6-K | 2014-06-06 | TRANSACTION IN OWN SHARES | gsk201406066k.htm |
| 2014-06-05 | 6-K | 2014-06-04 | TRANSACTION IN OWN SHARES | gsk201406056k1.htm |
| 2014-06-05 | 6-K | 2014-06-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201406056k.htm |
| 2014-06-04 | 6-K | 2014-06-04 | TRANSACTION IN OWN SHARES | gsk201406046k.htm |
| 2014-06-03 | 6-K | 2014-05-30 | TRANSACTION IN OWN SHARES | gsk201406036k.htm |
| 2014-06-02 | 6-K | 2014-06-02 | TRANSACTION IN OWN SHARES | gsk201406026k2.htm |
| 2014-06-02 | 6-K | 2014-06-02 | TOTAL VOTING RIGHTS | gsk201406026k.htm |
| 2014-05-30 | 6-K | 2014-05-30 | TRANSACTION IN OWN SHARES | gsk201405306k.htm |
| 2014-05-29 | 6-K | 2014-05-29 | TRANSACTION IN OWN SHARES | gsk201405296k.htm |
| 2014-05-28 | 6-K | 2014-05-28 | TRANSACTION IN OWN SHARES | gsk201405286k2.htm |
| 2014-05-28 | 6-K | 2014-05-28 | SERIOUS FRAUD OFFICE INVESTIGATION | gsk201405286k.htm |
| 2014-05-27 | 6-K | 2014-05-27 | TRANSACTION IN OWN SHARES | gsk201405276k2.htm |
| 2014-05-27 | 6-K | 2014-05-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201405276k.htm |
| 2014-05-23 | 6-K | 2014-05-23 | TRANSACTION IN OWN SHARES | gsk201405236k.htm |
| 2014-05-21 | 6-K | 2014-05-21 | TRANSACTION IN OWN SHARES | gsk201405216k.htm |
| 2014-05-20 | 6-K | 2014-05-20 | TRANSACTION IN OWN SHARES | gsk201405206k.htm |
| 2014-05-19 | 6-K | 2014-05-19 | TRANSACTION IN OWN SHARES | gsk201405196k.htm |
| 2014-05-16 | 6-K | 2014-05-16 | TRANSACTION IN OWN SHARES | gsk201405166k3.htm |
| 2014-05-16 | 6-K | 2014-05-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201405166k2.htm |
| 2014-05-16 | 6-K | 2014-05-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201405166k1.htm |
| 2014-05-16 | 6-K | 2014-05-16 | DIRECTOR DECLARATION | gsk201405166k.htm |
| 2014-05-15 | 6-K | 2014-05-15 | TRANSACTION IN OWN SHARES | gsk201405156k.htm |
| 2014-05-14 | 6-K | 2014-05-14 | BLOCKLISTING INTERIM REVIEW | gsk201405146k.htm |
| 2014-05-13 | 6-K | 2014-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201405136k3.htm |
| 2014-05-13 | 6-K | 2014-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201405136k2.htm |
| 2014-05-13 | 6-K | 2014-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201405136k1.htm |
| 2014-05-13 | 6-K | 2014-05-13 | DARAPLADIB PHASE III SOLID STUDY RESULTS | gsk201405136k.htm |
| 2014-05-12 | 6-K | 2014-05-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201405126k1.htm |
| 2014-05-12 | 6-K | 2014-05-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201405126k.htm |
| 2014-05-09 | 6-K | 2014-05-09 | TRANSACTION IN OWN SHARES | gsk201405096k.htm |
| 2014-05-08 | 6-K | 2014-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201405086k4.htm |
| 2014-05-08 | 6-K | 2014-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201405086k3.htm |
| 2014-05-08 | 6-K | 2014-05-08 | TRANSACTION IN OWN SHARES | gsk201405086k2.htm |
| 2014-05-08 | 6-K | 2014-05-08 | GSK RECEIVES EU MARKETING AUTHORISATION FOR ANORO | gsk201405086k1.htm |
| 2014-05-08 | 6-K | 2014-05-08 | BOARD COMMITTEE CHANGE | gsk201405086k.htm |
| 2014-05-07 | 6-K | 2014-05-07 | TRANSACTION IN OWN SHARES | gsk201405076k2.htm |
| 2014-05-07 | 6-K | 2014-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201405076k1.htm |
| 2014-05-07 | 6-K | 2014-05-07 | RESULT OF AGM | gsk201405076k.htm |
| 2014-05-06 | 6-K | 2014-05-06 | TRANSACTION IN OWN SHARES | gsk201405066k2.htm |
| 2014-05-06 | 6-K | 2014-05-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201405066k.htm |
| 2014-05-02 | 6-K | 2014-05-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201405026k4.htm |
| 2014-05-02 | 6-K | 2014-05-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201405026k5.htm |
| 2014-05-02 | 6-K | 2014-05-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201405026k3.htm |
| 2014-05-02 | 6-K | 2014-05-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201405026k2.htm |
| 2014-05-02 | 6-K | 2014-05-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201405026k.htm |
| 2014-05-01 | 6-K | 2014-05-01 | TOTAL VOTING RIGHTS | gsk201405016k2.htm |
| 2014-05-01 | 6-K | 2014-05-01 | GSK RECEIVES US APPROVAL FOR INCRUSE ELLIPTA | gsk201405016k.htm |
| 2014-04-30 | 6-K | 2014-04-30 | 1ST QUARTER RESULTS | gsk201404306k.htm |
| 2014-04-28 | 6-K | 2014-04-28 | GSK RECEIVES EU MARKETING AUTHORISATION - INCRUSE | gsk201404286k1.htm |
| 2014-04-28 | 6-K | 2014-04-28 | DIRECTOR/PDMR SHAREHOLDING | gsk201404286k.htm |
| 2014-04-22 | 6-K | 2014-04-22 | GSK ANNOUNCES MAJOR TRANSACTION WITH NOVARTIS | gsk201404226k.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k6.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k4.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k2.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k7.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k5.htm |
| 2014-04-17 | 6-K | 2014-04-17 | GSK RECEIVES APPROVAL IN CANADA FOR INCRUSE | gsk201404176k1.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k3.htm |
| 2014-04-17 | 6-K | 2014-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201404176k.htm |
| 2014-04-15 | 6-K | 2014-04-11 | TANZEUM (ALBIGLUTIDE) RECEIVES FDA APPROVAL | gsk201404156k2.htm |
| 2014-04-15 | 6-K | 2014-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201404156k1.htm |
| 2014-04-15 | 6-K | 2014-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201404156k.htm |
| 2014-04-14 | 6-K | 2014-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201404146k.htm |
| 2014-04-11 | 6-K | 2014-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201404116k2.htm |
| 2014-04-11 | 6-K | 2014-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201404116k1.htm |
| 2014-04-11 | 6-K | 2014-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201404116k.htm |
| 2014-04-10 | 6-K | 2014-04-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201404106k1.htm |
| 2014-04-10 | 6-K | 2014-04-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201404106k.htm |
| 2014-04-08 | 6-K | 2014-04-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201404086k1.htm |
| 2014-04-08 | 6-K | 2014-04-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201404086k.htm |
| 2014-04-02 | 6-K | 2014-04-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201404026k1.htm |
| 2014-04-02 | 6-K | 2014-04-02 | UPDATE ON PHASE LLL CLINICAL TRIAL OF MAGE-A3 | gsk201404026k.htm |
| 2014-04-01 | 6-K | 2014-04-01 | TOTAL VOTING RIGHTS | gsk201404016k.htm |
| 2014-03-31 | 6-K | 2014-03-31 | DIRECTOR/PDMR SHAREHOLDING | gsk201403316k1.htm |
| 2014-03-31 | 6-K | 2014-03-31 | GSK DATA FROM PIII STABILITY STUDY OF DARAPLADIB | gsk201403316k.htm |
| 2014-03-26 | 6-K | 2014-03-26 | EPERZAN (ALBIGLUTIDE) RECEIVES EMA APPROVAL | gsk201403266k2.htm |
| 2014-03-26 | 6-K | 2014-03-26 | NOTICE OF AGM | gsk201403266k1.htm |
| 2014-03-26 | 6-K | 2014-03-26 | REGULATORY UPDATE ON COMBINED USE OF MEK/BRAF | gsk201403266k.htm |
| 2014-03-24 | 6-K | 2014-03-24 | DIRECTOR/PDMR SHAREHOLDING | gsk201403246k.htm |
| 2014-03-21 | 6-K | 2014-03-21 | GSK - HISTORICAL RESTATED FINANCIAL INFORMATION | gsk201403216k.htm |
| 2014-03-20 | 6-K | 2014-03-17 | MAGE-A3 MAGRIT PHASE III TRIAL RESULTS | gsk201403206k.htm |
| 2014-03-17 | 6-K | 2014-03-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201403176k1.htm |
| 2014-03-17 | 6-K | 2014-03-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201403176k.htm |
| 2014-03-13 | 6-K | 2014-03-13 | ADDITIONAL LISTING | gsk201403136k.htm |
| 2014-03-12 | 6-K | 2014-03-12 | MEPOLIZUMAB POSITIVE PHASE III ASTHMA STUDY RESULT | gsk201403126k1.htm |
| 2014-03-12 | 6-K | 2014-03-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201403126k.htm |
| 2014-03-12 | 6-K | 2014-03-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201403126k2.htm |
| 2014-03-10 | 6-K | 2014-03-10 | GSK INCREASES STAKE IN ITS INDIAN PHARMA. CO. | gsk201403106k.htm |
| 2014-03-06 | 6-K | 2014-03-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201403066k.htm |
| 2014-03-05 | 6-K | 2014-03-05 | DIVIDEND DECLARATION | gsk201403056k.htm |